Probiotic Potential of Bacillus licheniformis and Bacillus pumilus Isolated from Tibetan Yaks, China

被引:0
作者
Zhibo Zeng
Jiabin Zhang
Yan Li
Kewei Li
Saisai Gong
Feiran Li
Pengpeng Wang
Mudassar Iqbal
Muhammad Fakhar-e-Alam Kulyar
Jiakui Li
机构
[1] Huazhong Agricultural University,College of Veterinary Medicine
[2] Tibet Agricultural and Animal Husbandry University,College of Animals Husbandry and Veterinary Medicine
[3] The Islamia University of Bahawalpur,Faculty of Veterinary and Animal Sciences
来源
Probiotics and Antimicrobial Proteins | 2022年 / 14卷
关键词
Yaks; Tibet; Antioxidant capacity; Probiotics;
D O I
暂无
中图分类号
学科分类号
摘要
Yak (Bos grunniens) inhabit an oxygen-deficient environment at the altitude of 3000 m on the Tibetan Plateau, with a distinctive gut micro-ecosystem. This study evaluated the probiotic potential and physiological property of Bacillus licheniformis and Bacillus pumilus isolated from the gut of yaks. Four strains, two Bacillus licheniformis (named D1 and D2) and two Bacillus pumilus (named X1 and X2), were isolated and identified by 16S rRNA sequencing. All strains had potential antibacterial ability against three indicator pathogens: Escherichia coli C83902, Staphylococcus aureus BNCC186335, and Salmonella enteritidis NTNC13349. The antioxidant activity test showed that D2 sample showed the highest antioxidant activity. Furthermore, all four strains had a higher hydrophobicity, auto-aggregation, acid tolerance, bile tolerance, and antibiotic sensitivity, which all contribute to their survival in the gastrointestinal tract and clinical utility. The animal experimentation (40 KM mice, equally divided into five groups of eight mice each) showed that the strain supplementation not only increased daily weight gain and reduced feed conversion ratio, but also increased the length of the jejunum villi and the value of the V/C (Villi/Crypt). In conclusion, this is the first study demonstrated the probiotic potential of Bacillus licheniformis and Bacillus pumilus isolated from yaks, providing a theoretical basis for the clinical application and development of new feed additives.
引用
收藏
页码:579 / 594
页数:15
相关论文
共 174 条
  • [1] Lederberg J(2001)Biological warfare Emerg Infect Dis 7 1071-1072
  • [2] Milani C(2017)The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota Microbiol Mol Biol Rev 1693 128-133
  • [3] Duranti S(2018)Neurotransmitter modulation by the gut microbiota Brain Res 11 506-514
  • [4] Bottacini F(2017)Microbiota-brain-gut axis and neurodegenerative diseases Curr Neurol Neurosci Rep 9 171-182
  • [5] Strandwitz P(2018)Gut microbiota in the pathogenesis of inflammatory bowel disease Clin J Gastroenterol 78 322-330
  • [6] Quigley EMM(2014)Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic Nat Rev Gastroenterol Hepatol 8 484-494
  • [7] Nishida A(2020)Probiotics and the microbiota-gut-brain axis: focus on psychiatry Curr Nutr Rep 46 769-782
  • [8] Inoue R(2018)Probiotic potential of Bacillus velezensis JW: antimicrobial activity against fish pathogenic bacteria and immune enhancement effects on Carassius auratus Fish Shellfish Immunol 11 705-713
  • [9] Inatomi O(2017)Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation Adv Nutr 22 2179-2194
  • [10] Hill C(2017)Probiotics in Inflammatory bowel disease Gastroenterol Clin North Am 73 316-320